Analgesic Treatment Mediated by Arcoxia (0663-093)

Phase 4

Completed

• Conditions: Pain

• Registration Number: NCT00380523
• Lead Sponsor: Organon and Co

Brief Summary

Allow physicians to test the efficacy of arcoxia in patients with acute pain.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-04
• Primary Completion: 2005-05
• Study Completion: 2005-05
• Study First Submitted: 2006-09-22
• Study First Submitted QC: 2006-09-22
• Study First Posted: 2006-09-26
• Status Verified: 2022-02
• Last Update Submitted: 2022-02-04
• Last Update Posted: 2022-02-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 237

Inclusion Criteria

• Diagnosis of acute pain susceptible of pharmacological treatment
• Greater than 18 years of age
• Voluntary acceptance to participate in the study and signature of the informed consent form

Exclusion Criteria

• Allergy to etoricoxib or any of its components
• Less than 18 years old
• Patient is taking anticoagulants
• Patient that already has taken any drug as analgesic

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Evaluate pain using the verbal analog scale (evaluate pain before starting treatment and then evaluate pain every day after had taken arcoxia up to three days)

Secondary Outcome Measures

Name	Time	Method
Patient satisfaction with the drug therapy using PGART scale
Patient satisfaction was obtained at the end of treatment(on third day)